News

German researchers studying tuberculosis that spreads beyond the lungs identified unique immune patterns in patients’ blood. These patterns reveal how the body fights the infection and could lead to a simple blood test to replace biopsies.

Single-cell RNA sequencing identified distinct immune profiles in extrapulmonary TB, linking interferon–IL-1 signaling to disease progression and paving the way for blood-based diagnostics.

A nationwide study in Scotland confirms that HPV vaccination provides strong, lasting protection against cervical precancer for more than a decade. Women vaccinated at ages 12–13 showed up to 82% reduced risk of high-grade lesions.

Scientists found that long-term, low doses of THC reduced inflammation and liver toxicity caused by HIV and antiretroviral therapy. The treatment increased serotonin and healthy gut bacteria while lowering harmful bile acids.

Long COVID in women is linked to gut leakiness, chronic inflammation and reduced testosterone, pointing to biological causes of sex-specific symptom severity.

A research team from Trinity has unveiled a groundbreaking new approach to vaccination that could redefine how we protect against respiratory infections.

Bacteria can spread by sugar-driven “swashing” or by gear-controlled gliding, redefining how microbes colonize surfaces and cause infection.

Scientists have used their discovery of previously unknown mechanisms in an anti-inflammatory pathway to develop a powerful upgrade: an engineered antibody that delivers the effectiveness of IVIG at fraction of the dose in mice.

A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable cases of triple-negative breast cancer — a form of cancer that is notoriously aggressive and lacks effective treatments.

According to researchers, IL-15 triggers harmful T-cell activation, but the calcineurin–NFAT pathway acts as a brake, suggesting new therapeutic strategies for autoimmune and viral diseases.